Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Parkway Life Real Estate Investment Trust

C2PU
Current price
3.58 SGD -0.03 SGD (-0.83%)
Last closed 3.61 SGD
ISIN SG1V52937132
Sector Real Estate
Industry REIT - Healthcare Facilities
Exchange Singapore Stock Exchange
Capitalization 2 379 368 347 SGD
Yield for 12 month +4.99 %
1Y
3Y
5Y
10Y
15Y
C2PU
21.11.2021 - 28.11.2021

Parkway Life Real Estate Investment Trust ("PLife REIT") is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 63 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.23 billion5 as at 31 December 2023. It owns the largest portfolio of strategically located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 59 assets of high-quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia. Address: 9 Raffles Place, Singapore, Singapore, 048619

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.22 SGD

P/E ratio

21.2941

Dividend Yield

5.83 %

Current Year

+148 066 782 SGD

Last Year

+130 950 842 SGD

Current Quarter

Last Quarter

Current Year

+125 020 514 SGD

Last Year

+122 785 809 SGD

Current Quarter

Last Quarter

Key Figures C2PU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM 81.35 %
PE Ratio 21.2941
Return On Assets TTM 3.25 %
PEG Ratio
Return On Equity TTM 7.41 %
Wall Street Target Price 6.22 SGD
Revenue TTM 146 144 412 SGD
Book Value 2.37 SGD
Revenue Per Share TTM
Dividend Share 0.15 SGD
Quarterly Revenue Growth YOY -1.2 %
Dividend Yield 5.83 %
Gross Profit TTM 108 904 045 SGD
Earnings per share 0.17 SGD
Diluted Eps TTM 0.17 SGD
Most Recent Quarter I 2023
Quarterly Earnings Growth YOY 0.6 %
Profit Margin 67.93 %

Dividend Analytics C2PU

Dividend growth over 5 years

6 %

Continuous growth

1 year

Payout Ratio 5 years average

59 %

Dividend History C2PU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.15
Ex Dividend Date 29.10.2024
Forward Annual Dividend Yield 4.18 %
Last Split Factor
Payout Ratio 85.18 %
Last Split Date
Dividend Date

Stock Valuation C2PU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 21.2941
Forward PE 19.9601
Enterprise Value Revenue 21.3961
Price Sales TTM 16.146
Enterprise Value EBITDA 24.6377
Price Book MRQ 1.6439

Financials C2PU

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators C2PU

For 52 weeks

3.24 SGD 4.31 SGD
50 Day MA 3.97 SGD
Shares Short Prior Month
200 Day MA 3.69 SGD
Short Ratio
Shares Short
Short Percent